Home / Resources / Articles (page 7)

Articles

The list of articles below are ordered by most recent. You will find articles here that are also listed in other categories. The list below is a catch-all for all articles on the site.

Diabetic Eye Disease May Start Years Before Your Eye Exam Finds It

Patient undergoing advanced retinal imaging with OCT scan displaying early retinal changes associated with diabetic eye disease before visible diabetic retinopathy.

Diabetes affects far more than blood sugar. In fact, the earliest stages of diabetic retinal disease may begin years before an eye doctor can see the classic signs of diabetic retinopathy during a routine examination. Imagine a smoke detector that alerts you before you ever see flames. That is the …

Read More »

A Newly Discovered Form of Cell Death May Explain Why Diabetes Causes So Many Complications

Scientific illustration showing ferroptosis, an iron-dependent form of cell death, contributing to diabetic complications affecting the kidneys, eyes, nerves, and heart.

Diabetes is known for raising blood sugar levels, but its long-term complications often have the greatest impact on health. Kidney disease, vision loss, nerve damage, and cardiovascular disease affect millions of people living with diabetes. For years, researchers focused on inflammation, oxidative stress, and poor circulation to explain these complications. …

Read More »

The Blood Vessel Damage Doctors Can’t See—Until It’s Too Late

Medical illustration showing the endothelial glycocalyx lining healthy blood vessels with a magnified view of microscopic vascular damage associated with diabetes.

Most people think diabetes-related blood vessel damage begins only after years of high blood sugar. However, scientists are uncovering evidence that injury may start much earlier, in a structure so thin it cannot be seen during a routine medical exam. This microscopic layer, known as the endothelial glycocalyx, acts as …

Read More »

Could Too Much Protein Be Affecting Insulin? Scientists Take a Closer Look

Protein-rich foods alongside a glucose meter and molecular model illustrating how branched-chain amino acid metabolism may influence insulin secretion and diabetes risk.

New research is changing the conversation around protein and metabolic health. For years, high-protein diets have been praised for supporting weight loss, preserving muscle, and improving blood sugar control. However, scientists are now discovering that the story may be more complex. Rather than blaming protein itself, researchers are focusing on …

Read More »

Could Your “Type 2” Patient Actually Have a Different Disease? New Trial Challenges Diabetes Treatment

Endocrinologist discussing precision treatment options with a patient diagnosed with HNF1A-MODY while reviewing genetic testing and diabetes management results.

When a person develops diabetes at a young age, is not overweight, and has several family members with the condition, is it really type 2 diabetes? In many cases, the answer may be no. A growing body of evidence suggests that thousands of people worldwide are living with HNF1A-MODY, a …

Read More »

Why Some Young Adults Lose Diabetes Control After Leaving Pediatric Care

Young adult with type 1 diabetes transitioning from a pediatric diabetes clinic to an adult endocrinology practice, illustrating the challenges of the transition to adult diabetes care.

The transition from pediatric to adult diabetes care is one of the most challenging periods in the lives of young people with diabetes. While many adolescents successfully manage their condition with the support of pediatric diabetes teams, moving into adult healthcare often coincides with worsening blood glucose control, missed appointments, …

Read More »

Not All Diabetic Kidney Disease Is the Same—Scientists Just Found a Hidden Subtype

Medical illustration showing a human kidney with an enlarged view of immune B-cell activity, representing a newly discovered diabetic kidney disease subtype associated with kidney inflammation.

For years, diabetic kidney disease (DKD) has been viewed as a single condition that progresses in a fairly predictable way. However, new research suggests that this assumption may overlook important biological differences between patients. Scientists have now identified a previously hidden subtype of diabetic kidney disease marked by increased B-cell …

Read More »

When High Triglycerides Become Dangerous: A New Drug May Help Prevent Pancreatitis

Medical illustration showing the pancreas, elevated triglycerides in the bloodstream, a glucose meter, and a person with abdominal pain representing pancreatitis risk in people with diabetes.

People with diabetes often focus on blood sugar, A1C, and cholesterol. However, very high triglyceride levels deserve just as much attention because they can trigger acute pancreatitis, a painful and potentially life-threatening condition. The connection between diabetes, high triglycerides, and pancreatitis is especially important because severe hypertriglyceridemia can develop silently …

Read More »

A Cholesterol Breakthrough for Diabetes? The First Oral PCSK9 Drug Has Arrived

Prescription pill beside a cholesterol-clogged artery illustration representing the first oral PCSK9 inhibitor for lowering LDL cholesterol in people with diabetes.

For many people with diabetes, lowering LDL cholesterol is just as important as controlling blood sugar. However, not everyone reaches their cholesterol goals with statins alone, and injectable PCSK9 inhibitors can be inconvenient or intimidating. Now, a new option has arrived. The FDA has approved the first oral PCSK9 inhibitor, …

Read More »

Farxiga Just Went Generic—Will Lower Prices Finally Change Diabetes Care?

Prescription bottle of generic dapagliflozin (Farxiga) beside a blood glucose meter, stethoscope, heart model, and kidney model representing diabetes, cardiovascular, and kidney care.

For many people living with type 2 diabetes, the biggest challenge is not finding an effective medication. It is being able to afford it. That reality may begin to change now that the U.S. Food and Drug Administration (FDA) has approved the first generic versions of Farxiga (dapagliflozin), potentially making …

Read More »